Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patients

G. R. HusebØ, M. Aanerud, T. Ueland, J. A. Hardie, P. S. Bakke, T. M. Eagan (Bergen, Oslo, Norway)

Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Session: Factors associated with outcomes in COPD
Session type: Thematic Poster Session
Number: 4222
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. R. HusebØ, M. Aanerud, T. Ueland, J. A. Hardie, P. S. Bakke, T. M. Eagan (Bergen, Oslo, Norway). Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patients. Eur Respir J 2013; 42: Suppl. 57, 4222

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

LSC - 2019 - Neutrophil gelatinase-associated lipocalin and IL-6 – markers predictors for exacerbations in Asthma- COPD overlap, compared to COPD and Asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Human neutrophil gelatinase-associated lipocalin: A new biomarker in asthma-COPD overlap syndrome
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1807-1809
Year: 2014


Usefulness of the measurement of plasma neutrophil gelatinase-associated lipocalin as a biomarker for predicting prognosis in hospitalized patients with pneumonia
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Increased levels of human myeloperxidase (MPO) and neutrophil lipocalin (HNL/NGAL) in childhood asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Neutrophil elastase and IL-8 assessment in patients with COPD and asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 61s
Year: 2005

Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity?
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Pro-surfactant protein B, a promising BAL biomarker of COPD progression in heavy smokers, is increased by budesonide/formoterol short-term therapy
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013

Blood eosinophils relate more closely to reduced lung function than serum ECP or plasma EDN in young asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF
Source: ERS Lung Science Conference 2021
Year: 2021

Concentration of C-reactive protein (CRP) in elderly asthmatics
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015